Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Monoclonal Gammopathy of Renal Significance
Chapel Hill, North Carolina
Monoclonal Gammopathy of Renal Significance Clinical Trials in Chapel Hill, North Carolina
1 recruiting
Chapel Hill, North Carolina
Showing
1–1
of
1
trials
Recruiting
Phase 2
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Multiple Myeloma
Monoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer Center
20 enrolled
11 locations
NCT06083922
Feedback